RxDoctor Payments Data

Peter Brady, MD

Clinical Cardiac Electrophysiology · Chicago, ILNPI 1215901301

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,150 of the $61,296 with a category attached, or 60.6%. Abbott accounts for 88.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $42,922 and has fallen 99.7% since, to $122 in 2025.

$61,296in general payments, 2019–2025

Across 227 payments — averaging $270.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$54K
  • Philips North America LLC$4K
  • Biotronik Inc.$948
  • Biosense Webster, Inc.$705
  • Medtronic$363
  • Boston Scientific$267
  • plus $568 from 7 others
$10,848in research payments, 2019–2025

Across 9 payments — averaging $1205.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$11K

What the payments were for

  • Consulting fees$37,15061%
  • Speaking & faculty fees$6,37510%
  • Travel & lodging$8,37914%
  • Food & beverage$9,38015%
  • Education$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,296 in reported general payments places this provider in the 80th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$132,859
Medicare patients
1,575
Services billed
3,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$147,009
XareltoRivaroxaban21$27,218
Dofetilide22$6,870
Flecainide Acetate21$804
Metoprolol Succinate41$491
Amiodarone Hcl24$298
Warfarin Sodium28$234
SotalolSotalol Hcl13$91
Metoprolol Tartrate23$44

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →